Goldman Sachs Reinstates Kodiak Sciences Inc. (KOD) at Sell, 'Cautious on the tarcocimab reboot'
Tweet Send to a Friend
(Updated - December 11, 2023 6:26 AM EST)
Goldman Sachs analyst Andrea Tan reinstates coverage on Kodiak Sciences Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Andrea Tan reinstates coverage on Kodiak Sciences Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
